Wolde Hailu Demissie: Moving Beyond the 4.5-Hour Window in Wake-Up Stroke
Wolde Hailu Demissie, Internist at RDDMH, shared on LinkedIn about a recent article by Mehari Gebreyohanns et al, published in Frontiers, adding:
”Wake-up stroke is a stroke with unknown onset time.
Often excluded from tPA treatment due to the absence of a standardized approach.
Interestingly 25% of acute ischemic strokes are wake-up strokes.
Due to the uncertain onset of symptoms, only about 8–27% of patients experiencing wake-up strokes receive thrombolytic therapy as 4.5hr not include those patient .
The bottom line is: MRI can be crucial in estimating the ischemic core and penumbra, guiding decisions on thrombolytic therapy for these patients .
30% of patients with wake-up stroke with negative fluid attenuated inversion recovery (FLAIR) and a visible acute ischemic lesion on diffusion weighted imaging (DWI) findings on MRI, or simply MRI mismatch, may be candidates for thrombolytic therapy.
Both tPA and EVT in these patients improve functional outcomes without increasing the risk of death.
In general MRI revolutionized stroke management with early papers on New England Journal of Medicine to support the the same concept.
Negative FLAIR with visible DWI is what you look for the stroke management not only 4.5 hr!
And above MRI finding may perisist up to 9hr so imaging with this hr for wake up stroke from last time he/she went to bed is paramount important to 4.5 hours.”
Title: Identifying wakeup stroke routine treatments in the emergency departments
Authors: Mehari Gebreyohanns, Sidarrth Prasad, Kim D. Barker, Joshua D. E. Amos, Erica M. Jones, Lindsay M. Riskey, Daiwai M. Olson, Asmiet K. Techan, Ty A. Johnson, Nneka L. Ifejika
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 2, 2026, 19:26Dhinesh Selvaraju: FDA Expands Access to HYMPAVZI in Hemophilia
-
Jul 2, 2026, 19:13Syed Fahad Hussain: Not Every Low Platelet Count Tells the Same Story
-
Jul 2, 2026, 18:59Indu Thakur: Supporting Blood Donation Through Public Awareness in MSBT
-
Jul 2, 2026, 18:47Vee Townsend: IMHUE Highlights 9 Myths and Facts About Hemophilia B
-
Jul 2, 2026, 17:17Nico Gagelmann: Launching Myths and Facts on Hematology and Cell Therapy
-
Jul 2, 2026, 17:05Haroun Gajraj: Understanding the Technology Behind Spider Vein Treatment
-
Jul 2, 2026, 16:44Ney Carter Borges: Is It Time to Personalize Antiplatelet Therapy?
-
Jul 2, 2026, 16:22Introducing a New Resource for the ITP Community – ITP Support Association
-
Jul 2, 2026, 16:22Shinto Francis Thekkudan: Delegates Visiting our BMT and Hematology Department from Kazhakstan